Micronization of etoposide using solution-enhanced dispersion by supercritical CO2
-
Add time:09/02/2019 Source:sciencedirect.com
To improve the solubility and dissolution rate of etoposide, micro-particles were prepared using solution-enhanced dispersion by supercritical CO2, and the transition of crystal form was investigated using scanning electron microscopy, X-ray diffraction, thermogravimetric analysis, and differential scanning calorimetry. The effects of various operating parameters, including precipitation pressure, temperature, the etoposide concentration, and solution flow rate were investigated. The results showed that the particle size of etoposide can be controlled, and smaller particles of 586 nm were successively obtained. A reduction in the particle size led to an increase in the dissolution rate. Furthermore, at a precipitation pressure ≥18 MPa, a new polymorphic form was discovered, which exhibited higher solubility and faster dissolution rate.
We also recommend Trading Suppliers and Manufacturers of Etoposide phosphate (cas 117091-64-2). Pls Click Website Link as below: cas 117091-64-2 suppliers
Prev:RESEARCHPhysical and Chemical Stability of Etoposide phosphate (cas 117091-64-2) Solutions
Next:Short communicationDetermination of Etoposide phosphate (cas 117091-64-2) intermediates by gradient liquid chromatography using postcolumn derivatization with cuprammonium hydroxide) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Short communicationDetermination of Etoposide phosphate (cas 117091-64-2) intermediates by gradient liquid chromatography using postcolumn derivatization with cuprammonium hydroxide09/03/2019
- RESEARCHPhysical and Chemical Stability of Etoposide phosphate (cas 117091-64-2) Solutions09/01/2019
- Short communicationPhase I and pharmacokinetic study of a water-soluble etoposide prodrug, Etoposide phosphate (cas 117091-64-2) (BMY-40481)08/31/2019
- In vitro and in vivo evaluation of etoposide - silk wafers for neuroblastoma treatment08/30/2019
- Etoposide phosphate (cas 117091-64-2) or etoposide with cisplatin in the treatment of small cell lung cancer: Randomized Phase II trial08/29/2019
- Optimization by design of etoposide loaded solid lipid nanoparticles for ocular delivery: Characterization, pharmacokinetic and deposition study08/28/2019
- In-vitro dissolution and microbial inhibition studies on anticancer drug etoposide with β-cyclodextrin08/27/2019
- Research ArticlePharmaceutics, Drug Delivery and Pharmaceutical TechnologyTransdermal Delivery of Etoposide phosphate (cas 117091-64-2) II: In Vitro In Vivo Correlations (IVIVC)08/26/2019
- Research ArticlePharmaceutics, Drug Delivery and Pharmaceutical TechnologyTransdermal Delivery of Etoposide phosphate (cas 117091-64-2) I: In Vitro and In Vivo Evaluation08/25/2019


